Axelium
6.6#14 in ai literature review softwareFrom $29 a monthFree planWebExtension
VisitAxelium vs Rayyan
What both publish
| Fact | Axelium | Rayyan |
|---|---|---|
| Audience | The site describes use for individual researchers, pharma and HEOR teams, CROs and consultancies, HTA bodies, and clinical guideline committees. | Rayyan describes its intended organization users as pharma, medical-device, CRO, university, healthcare, government, and health technology assessment teams. |
| Integrations | It lists reference imports from EndNote, Zotero, Mendeley, Embase, and Web of Science; database sources include PubMed, ClinicalTrials.gov, EuropePMC, OpenAlex, CENTRAL, MAUDE, and ERIC. | Rayyan accepts exported reference files from external databases and reference managers; it says there is no direct database connection. |
| Support | The contact page provides [email protected] for existing users and says the team replies within 1–2 business days. | The pricing page lists Standard support for Free and Essential, priority support for Advanced and Business / Academic, and dedicated support for Enterprise. |
| Workflow | Its listed 11-stage workflow includes protocol, search, screening, full-text, extraction, RoB 2.0, GRADE, statistics, network meta-analysis, reporting, and living reviews. | Its review workflow covers reference import, collaboration, deduplication, title and abstract screening, full-text screening, data extraction, risk-of-bias assessment, and reporting. |
Axelium plans
- FreeFree
- Researcher$29 a month
- Professional$79 a month
- Team$266 a month
- EnterprisePriced on request
Rayyan plans
- FreeFree
- Essential$4.99 a month
- Advanced$8.33 a month
- Business / Academic$41.67 a month
- EnterprisePriced on request
Pick Axelium if…
Axelium describes use by individual researchers, pharma and HEOR teams, CROs and consultancies, HTA bodies, and clinical guideline committees. It may suit reviewers who need structured review stages and team sign-off controls.
Pick Rayyan if…
It suits research teams screening and analysing evidence across a systematic review workflow. The intended organisation users include pharma, medical-device, CRO, university, healthcare, government, and health technology assessment teams.